Plasma membrane NADH-oxidoreductase system: A critical review of the structural and functional data

Antioxidants and Redox Signaling

Volumn 2, Issue 2, 2000, Pages 197-212

  Baker, Mark A ^a   Lawen, Alfons ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYTOCHROME B5 REDUCTASE; FERRICYANIDE; IRON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ANIMAL CELL; APOPTOSIS; BIOENERGY; CELL DIFFERENTIATION; CELL MEMBRANE; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; HUMAN; HUMAN CELL; IRON TRANSPORT; MITOGENESIS; NONHUMAN; PH; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; REVIEW; SECOND MESSENGER;

ANIMALIA; MAMMALIA;

EID: 0033936606     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.2-197     Document Type: Review

References (91)

1. ALCAÍN, F.J., BURÓN, M.I., RODRIGUEZ-AGUILERA, J.C., VILLALBA, J.M., and NAVAS, P. (1990). Ascorbate free radical stimulates the growth of a human promyelocytic leukemia cell line. Cancer Res. 50, 5887-5891.
2. ALCAÍN, F.J., BURÓN, M.I., VILLALBA, J.M. and NAVAS, P. (1991). Ascorbate is regenerated by HL-60 cells through the transplasmalemma redox system. Biochim. Biophys. Acta 1073, 380-385.
3. BALDWIN, D.A., DE SOUSA, D.M.R., and VON WANDRUSZKA, R.M.A. (1982). The effect of pH on the kinetics of iron release from human transferrin. Biochim. Biophys. Acta 719, 140-146.
4. BARNES, D., and SATO, G. (1980). Methods for growth of cultured cells in serum-free medium. Anal. Biochem. 102, 255-270.
5. BARROSO, M.P., GÓMEZ-DÍAZ, C., LÓPEZ-LLUCH, G., MALAGON, M.M., CRANE, F.L., and NAVAS, P. (1997). Ascorbate and a-tocopherol prevent apoptosis induced by serum removal independent of Bcl-2. Arch. Biochem. Biophys. 343, 243-248.
6. BERCZI, A., and FAULK, W.P. (1992). Iron-reducing activity of plasma membranes. Biochem. Int. 28, 577-584.
7. BRIGHTMAN, A.O., WANG, J, MIU, R.K.-M., SUN, I.L., BARR, R., CRANE, F.L., and MORRÉ, D.J. (1992). A growth factor-and hormone-stimulated NADH oxidase from rat liver plasma membrane. Biochim. Biophys. Acta 1105, 109-117.
8. BROOKS, M.M. (1947). Activation of eggs by oxidation-reduction indicators. Science 106, 320.
9. BRUDER, G., BRETSCHER, A., FRANKE, W.W., and JARASCH, E.D. (1980). Plasma membranes from intestinal microvilli and erythrocytes contain cytochromes 65 and P-420. Biochim. Biophys. Acta 600, 739-755.
10. BULLIARD, C., ZURBRIGGEN, R., TORNARE, J., FATY, M., DASTOOR, Z., and DREYER. J.-L. (1997). Purification of a dichlorophenol-indophenol oxidoreductase from rat and bovine synaptic membranes: tight complex association of a glyceraldehyde-3-phosphate dehydrogenase isoform, TOAD64, enolase-γ and aldolase C. Biochem. J. 324, 555-563.
11. BURON, M.I., RODRIGUEZ-AGUILERA, J.C., ALCAÍN, F.J., and NAVAS, P. (1993). Transplasma membrane redox system in HL-60 cells is modulated during TPA-induced differentiation. Biochem. Biophys. Res. Commun. 192, 439-445.
12. CHAUDIERE, J., and TAPPEL, A.L. (1984). Interaction of gold(I) with the active site of selenium-glutathione peroxidase. J. Inorg. Biochem. 20, 313-325.
13. CHUEH, P.J., MORRÉ, D.J., WILKINSON, F.E., GIBSON, J., and MORRÉ, D.M. (1997). A 33.5 kDa heat and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients. Arch. Biochem. Biophys. 342, 38-47.
14. CRANE, F.L., ROBERTS, H., LINNANE, A.W., and LÖW, H. (1982). Transmembrane ferricynide reduction by cells of the yeast Saccharomyces cerevisiae. J. Bioenerg. Biomembr. 14, 191-205.
15. CRANE, F.L., SUN, I.L., CLARK. M.G., GREBING, C., and LOW, H. (1985). Transplasma-membrane redox systems in growth and development. Biochim. Biophys. Acta 811, 233-264.
16. CROWE, R.A., TAPAROWSKY, E.J., and CRANE, F.L. (1993). Ha-ras stimulates the transplasma membrane oxidoreductase activity of C3H10T1/2 cells. Biochem. Biophys. Res. Commun. 196, 844-850.
17. CUNNINGHAM, C.C., DECHATELET, L.R., SPACH, P.I., PARCE, J.W., THOMAS, M.J., LEES, C.J., and SHIRLEY, P.S. (1982). Identification and quantitation of electron-transport components in human polymorphonuclear neutrophils. Biochim. Biophys. Acta 682, 430-435
18. DANCIS, A., KLAUSNER, R.D., HINNEBUSCH, A.G., and BARRIOCANAL, J.G. (1990). Genetic evidence that ferric reductase is required for iron uptake in Saccharomyces cerevisiae. Mol. Cell. Biol. 10, 2294-2301.
19. DEL CASTILLO-OLIVARES, A., MARQUEZ, J., NÚÑEZ DE CASTRO, I., and MEDINA, M.Á. (1994). Characterization of plasma membrane redox activity from Ehrlich cells. Cell. Biochem. Funct. 12, 149-152.
20. 2+ as second messengers. J. Bioenerg. Biomembr. 27, 605-611.
21. DEL CASTILLO-OLIVARES, A., ESTEBAN DEL VALLE, A., MÁRQUEZ, J., NÚÑEZ DE CASTRO, I., and MEDINA, M.Á. (1996). Effects of protein kinase C and phosphoprotein phosphatase modulators on Ehrlich cell plasma membrane redox system activity. Biochim. Biophys. Acta 1313, 157-160.
22. DORMANDY, T.L., and ZARDAY, Z. (1965). The mechanism of insulin action: the immediate electrochemical effects of insulin on red-cell systems. J. Physiol. 180, 684-707.
23. ELLEM, K.A.O., and KAY, G.F. (1983). Ferricyanide can replace pyruvate to stimulate growth and attachment of serum restricted human melanoma cells. Biochem. Biophys. Res. Commun. 112, 183-190.
24. GARCIA DE VEAS, R., SCHWEIGERER, L., and MEDINA, M.Á. (1995). Why is ascorbate toxic for neuroblastoma cell lines and why does this toxicity increase with cell line malignancy? Redox Rep. 1, 225-227.
25. GEORGATSOU, E., and ALEXANDRAKI, D. (1994). Two distinctly regulated genes are required for ferric reduction, the first step of iron uptake in Saccharomyces cerevisiae. Mol. Cell. Biol. 14, 3065-3073.
26. GEORGATSOU, E., and ALEXANDRAKI, D. (1999). Regulated expression of the Saccharomyces cerevisiae Frelp/Fre2p Fe/Cu reductase related genes. Yeast 15, 573-584.
27. GERSON, D.F., KIEFER, H., and EUFE, W. (1982). Intracellular pH of mitogen-stimulated lymphocytes. Science 216, 1009-1010.
28. 5 reductase of erythrocytes and liver microsomes. Biochim. Biophys. Acta 423, 293-302.
29. GREBING, C., CRANE, F.L., LÖW, H., and HALL, K. (1984). A transmembranous NADH-dehydrogenase in human erythrocyte membranes. J. Bioenerg. Biomembr. 16, 517-533.
30. GRUBB, D.R., WOLVETANG, E.J., and LAWEN, A. (1995). Didemnin B induces cell death by apoptosis: the fastest induction of apoptosis ever described. Biochem. Biophys. Res. Commun. 215, 1130-1136.
31. GUAIQUIL, V.H., FARBER, C.M., GOLDE, D.W., and VERA, J.C. (1997). Efficient transport and accumulation of vitamin C in HL-60 cells depleted of glutathione. J. Biol. Chem. 272, 9915-9921.
32. GUTIERREZ, J.A., INMAN, R.S., AKOMPONG, T., YU, J., and WESSLING-RESNICK, M. (1998). Metabolic depletion inhibits the uptake of nontransferrin-bound iron by K562 cells. J. Cell Physiol. 177, 585-592.
33. 13C-NMR studies of transmembrane electron transfer to extracellular ferricyanide in human erythrocytes. Eur. J. Biochem. 246, 638-645.
34. 13C-NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry 37, 7578-7588.
35. INMAN, R.S., and WESSLING-RESNICK, M. (1993). Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J. Biol. Chem. 268, 8521-8528.
36. INMAN, R.S., COUGHLAN, M.M., and WESSLINGRESNICK, M. (1994). Extracellular ferrireductase activity of K562 cells is coupled to transferrin-independent iron transport. Biochemistry 33, 11850-11857.
37. KEILIN, D., and HARTREE, E.F. (1946). Spectroscopic study of the permeability and lysis of red blood corpuscles. Nature 157, 210-213.
38. 0 cells. J. Biol. Chem. 269, 30097-30100.
39. LAWEN, A., MARTINUS, R.D., MCMULLEN, G.L., NAGLEY, P., VAILLANT, F., WOLVETANG, E.J., and LINNANE, A.W. (1994). The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase. Mol. Aspects Med. 15(Suppl.), s13-s27.
40. LAWEN, A., BAKER, M.A., and MALIK, S. (1998). Apoptosis and redox homeostasis - On a possible mechanism of action of Bcl-2. Protoplasma 205, 10-20.
41. LINNANE, A.W., BAUMER, A., MAXWELL, R.J., PRESTON, H., ZHANG, C.F., and MARZUKI, S. (1990). Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem. Int. 22, 1067-1076.
42. LOEPER, J., DESCATOIRE, V., MAURICE, M., BEAUNE, P., BELGHITI, J., HOUSSIN, D., BALLET, F., FELDMANN, G., GUENGERICH, F.P., and PESSAYRE, D (1993). Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104, 203-216.
43. LÖW, H., and CRANE, F.L. (1995). The NADH oxidizing system of the plasma membrane and metabolic signal control. Protoplasma 184, 158-162.
44. LÖW, H., and WERNER, S. (1976). Effects of reducing and oxidizing agents on the adenylate cyclase activity in adipocyte plasma membranes. FEBS Lett. 65, 96-98.
45. LÖW, H., CRANE, F.L., GREBING, C., ISAKSSON, M., LINDGREN, A., and SUN, I.L. (1991). Modification of transplasma membrane oxidoreduction by SV40 transformation of 3T3 cells. J. Bioenerg. Biomembr. 23, 903-917.
46. MAY, J.M. (1999). Is ascorbic acid an antioxidant for the plasma membrane. FASEB J. 13, 995-1006.
47. MAY, J.M., MENDIRATTA, S., HILL, K.E., and BURK, R.F. (1997). Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J. Biol. Chem. 272, 22607-22610.
48. MAY, J.M. QU, Z-C., and WHITESELL, R.R. (1998). Ascorbate is the major electron donor for a transmembrane oxidoreductase of human erythrocytes. Biochim. Biophys. Acta 1238, 127-289.
49. MEDINA, M.Á., SÁNCHEZ-JIMÉNEZ, F., SEGURA, J.A., and NÚÑEZ DE CASTRO, I. (1988). Transmembrane ferricyanide reductase activity in Ehrlich ascites tumor cells. Biochim. Biophys. Acta 946, 1-4.
50. MEDINA, M.Á., LUQUE, P., and NÚÑEZ DE CASTRO, I. (1991). Mitoxantrone toxicity on Ehrlich ascites tumour cells: inhibition of the transplasma membrane redox activity. Cell. Biochem. Funct. 9, 95-98.
51. MEDINA, M.Á., DEL CASTILLO-OLIVARES, A., and SCHWEIGERER, L. (1992a). Plasma membrane redox activity correlates with N-myc expression in neuroblastoma cells. FEBS Lett. 311, 99-101.
52. MEDINA, M.Á., SÁNCHEZ-JIMÉNEZ, F., MÁRQUEZ, J., RODRIGUEZ QUESADA, A., and NÚÑEZ DE CASTRO, I. (1992b). Relevance of glutamine metabolism to tumor cell growth. Mol. Cell Biochem. 113, 1-15.
53. MEDINA, M.Á., DEL CASTILLO-OLIVARES, A., MÁRQUEZ, J., and NÚÑEZ DE CASTRO, I. (1994). Involvement of essential histidine residue(s) in the activity of Ehrlich cell plasma membrane NADH-ferricyanide oxidoreductase. Biochim. Biophys. Acta 1190, 20-24.
54. MEDINA, M.Á., DEL CASTILLO-OLIVARES, A., and NÚÑEZ DE CASTRO, I. (1997). Multifunctional plasma membrane redox systems. Bioessays 19, 977-984.
55. MINTURN, J.E., FRYER, H.J., and HOCHFIELD, S. (1995). TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon growth. J. Neurosci. 15, 6757-6766.
56. MISHRA, R.K., and PASSOW, H. (1969). Induction of intracellular ATP synthesis by extracellular ferricyanide in human red blood cells. J. Membr. Biol. 1, 214-224.
57. MODUN, B., and WILLIAMS, P. (1999). The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect. Immun. 67, 1086-1092.
58. MORRÉ, D.J., and REUST, T. (1997). A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients. J. Bioenerg. Biomembr. 29, 281-289.
59. MORRÉ, D.J., KARTENBECK, J., and FRANKE, W.W. (1979). Membrane flow and intercoversions among endomembranes. Biochim. Biophys. Acta 559, 71-152.
60. MORRÉ D.J., CHUEH, P.J., and MORRÉ, D.M. (1995a). Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. USA 92, 1831-1835.
61. MORRÉ, D.J., WILKINSON, F.E., LAWRENCE, J., CHO, N., and PAULIK, M. (1995b). Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranes. Biochim. Biophys. Acta. 1236, 237-243.
62. MORRÉ, D.J., CALDWELL, S., MAYORGA, A., WU, L.Y., and MORRÉ, D.M. (1997). NADH-oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch. Biochem. Biophys. 342, 224-230.
63. MUSÍLKOVÁ, J., KRIEGERBECKOVÁ, K., KRŮŠEK, J., and KOVÁR, J. (1998). Specific binding to plasma membrane is the first step in the uptake of non-transferrin iron by cultured cells. Biochim. Biophys. Acta 1369, 103-108.
64. NAVAS, P., SUN, I.L., MORRÉ, D.J., and CRANE, F.L. (1986). Decrease of NADH in HeLa cells in the presence of transferrin or ferricyanide. Biochem. Biophys. Res. Commun. 135, 110-115.
65. OCTAVE, J-N., SCHNEIDER, Y-J., CRICHTON, R.R., and TROUET, A. (1983). Iron mobilization from cultured hepatocytes: effect of desferrioxamine B. Biochem. Pharmacol. 32, 3413-3418.
66. 2+-ATPase in isolated adipocyte plasma membranes. Nature 281, 495-497.
67. ROBINSON, N.J., PROCTER, C.M., CONNOLLY, E.L., and GUERINOT, M.L. (1999). A ferric-chelate reductase for iron uptake from soils. Nature 397, 694-697.
68. RODRIGUEZ-AGUILERA, J.C., NAVARRO, F., ARROYO, A., VILLALBA, J.M., and NAVAS, P. (1993). Transplasma membrane redox system of HL-60 cells is controlled by cAMP. J. Biol. Chem 268, 26346-26349.
69. ROMAN, D.G., DANCIS, A., ANDERSON, G.J., and KLAUSNER, R.D. (1993). The fission yeast ferric reductase gene frpl+ is required for ferric iron uptake and encodes a protein that is homologous to the gp91-phox subunit of the human NADPH phagocyte oxidoreductase. Mol. Cell. Biol. 13, 4342-4350.
70. ROSE, R.C. (1988). Transport of ascorbic acid and other water-soluble vitamins. Biochim. Biophys. Acta 947, 335-366.
71. ROVERA, G., SANTOLI, D., and DAMSKY, C. (1979). Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA 76, 2779-2783.
72. SCHWARTZMAN, R.A., and CIDLOWSKI, J.A. (1993). Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev. 14, 133-151.
73. SCHWEINZER, E., and GOLDENBERG, H. (1993). Monodehydroascorbate reductase activity in the surface membrane of leukemic cells. Characterization by a ferricyanide-driven redox cycle. Eur. J. Biochem. 218, 1057-1062.
74. SIJMONS, P.C., LANFERMEIJER, F.C., DE BOER, A.H., PRINS, H.B.A., and BIENFAIT, H.F. (1984). Depolarization of cell membrane potential during Trans-plasma membrane electron transfer to extracellular electron acceptors in iron-deficient roots of Phaseolus vulgaris L. Plant Physiol. 76, 943-946.
75. SUN, I.L., and CRANE, F.L. (1984). The antitumor drug, cis diamminedichloro-platinum, inhibits trans plasmalemma electron transport in HeLa cells. Biochem. Int. 9, 299-306.
76. SUN, I.L., and CRANE, F.L. (1985). Bleomycin control of transplasma membrane redox activity and proton movement in HeLa cells. Biochem. Pharmacol. 34, 617-622.
77. SUN, I.L., CRANE, F.L., GREBING, C., and LÖW, H. (1984). Properties of a transplasma membrane electron transport system in HeLa cells. J. Bioenerg. Biomembr. 16, 583-595.
78. + antiport activity. Biochim. Biophys. Acta 938, 17-23.
79. SUN, I.L., SUN, E.E., CRANE, F.L., MORRÉ, D.J., LINDGREN, A., and LÖW, H. (1992). Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 89, 11126-11130.
80. SZÉKELY, M., MÁNYAI, S., and STRAUB, F.B. (1952) Über den Mechanismus der osmotischen Hämolyse. Acta Physiol. Acad. Sci. Hung. 3, 571-583.
81. THOMAS, D., RITZ M.-F., MALVIYA, A.N., and GAILLARD, S. (1996). Intracellular acidification mediates the proliferative response of PC12 cells induced by potassium ferricyanide and involves MAP kinase activation. Int. J. Cancer 68, 547-552.
82. TRITTON, T.R., and YEE, G. (1982).The anitcancer agent adriamycin can be actively cytotoxic without entering cells. Science 217, 248-250.
83. VAILLANT, F., LARM, J.A., MCMULLEN, G.L., WOLVETANG E.J., and LAWEN, A. (1996). Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators. J. Bioenerg. Biomembr. 28, 531-540.
84. +-dependent transport systems for neutral amino acids. Biochim. Biophys. Acta 858, 181-187.
85. VAN DUIJN, M.M., VAN DER ZEE, J., VANSTEVENINCK, J., and VAN DEN BROEK, P.J.A. (1998). Ascorbate stimulates ferricyanide reduction in HL-60 cells through a mechanism distinct from the NADH-dependent plasma membrane reductase. J. Biol. Chem. 273, 13415-13420.
86. VOEGTLIN, C., JOHNSON, J.M., and DYER, H.A. (1925). Quantitative estimation of the reducting power of normal and cancer tissue. J. Pharmacol. Exp. Ther. 24, 305-334.
87. +) pump and partially removes the inhibition by vanadium ions. Biochem. Biophys. Res. Commun. 116, 783-790.
88. WANG, C-S., and ALAUPOVIC, P. (1978). Isolation and partial characterization of human erythrocyte membrane NADH: (acceptor) oxidoreductase. J. Supramol. Struct. 9, 1-14.
89. WILKINSON, F., KIM, C., CHO, N., CHUEH, P.-J., LESLIE, S., MOYA-CAMARENA, S., WU, L.-Y., MORRÉ, D.M., and MORRÉ, D.J. (1996). Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells. Arch. Biochem. Biophys. 336, 275-282.
90. WINKLER, B.S. (1987). In vitro oxidation of ascorbic acid and its prevention by GSH. Biochim. Biophys. Acta 925, 258-264.
91. WOLVETANG, E.J., LARM, J.A., MOUTSOULAS, P., and LAWEN, A. (1996). Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ. 7, 1315-1325.